Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury

Patients with liver diseases, especially those with cirrhosis, have an increased mortality risk when infected by SARS-CoV-2 and therefore anti-SARS-CoV-2 vaccine has been recommended by leading Scientific Associations for all patients with chronic liver diseases. However, previous reports have shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Lleo, Ana, Cazzagon, Nora, Rigamonti, Cristina, Cabibbo, Giuseppe, Lai, Quirino, Muratori, Luigi, Carbone, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:
Liver, Pancreas and Biliary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958090/
https://www.ncbi.nlm.nih.gov/pubmed/35410851
http://dx.doi.org/10.1016/j.dld.2022.03.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958090/
https://www.ncbi.nlm.nih.gov/pubmed/35410851
http://dx.doi.org/10.1016/j.dld.2022.03.014

Ejemplares similares